Cochrane corner: why we still don't know whether anti-TNF biologic therapies impact uveitic macular oedema

被引：4

作者：

Braithwaite, Tasanee ^{[1
,2
,3
]}

Davis, Nicki ^{[4
]}

Galloway, James ^{[5
]}

机构：

[1] Kings Coll Hosp NHS Fdn Trust, Ophthalmol Dept Uveitis, London, England

[2] Moorfields Eye Hosp NHS Fdn Trust London, Ophthalmol Dept Neuroophthalmol, London, England

[3] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[4] Olivias Vis, London, England

[5] Kings Coll London, Ctr Rheumat Dis, London, England

来源：

EYE | 2019年 / 33卷 / 12期

关键词：

ADALIMUMAB; PATIENT;

D O I：

10.1038/s41433-019-0481-4

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：1830 / 1832

页数：3

共 15 条

[1] Uveitis in the Aging Eye: Incidence, Patterns, and Differential Diagnosis [J].

Abdulaal, Marwan R. ;

Abiad, Bachir H. ;

Hamam, Rola N. .

JOURNAL OF OPHTHALMOLOGY, 2015, 2015

[2] Anti-tumour necrosis factor biological therapies for the treatment of uveiticmacular oedema (UMO) for noninfectious uveitis [J].

Barry, Robert J. ;

Tallouzi, Mohammad O. ;

Bucknall, Nick ;

Mathers, Jonathan M. ;

Murray, Philip I. ;

Calvert, Melanie J. ;

Moore, David J. ;

Denniston, Alastair K. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (12)

[3] The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice [J].

Braithwaite, Tasanee ;

Calvert, Melanie ;

Gray, Alastair ;

Pesudovs, Konrad ;

Denniston, Alastair K. .

[4] "The patient is speaking": discovering the patient voice in ophthalmology [J].

Dean, Samera ;

Mathers, Jonathan M. ;

Calvert, Melanie ;

Kyte, Derek G. ;

Conroy, Dolores ;

Folkard, Annie ;

Southworth, Sue ;

Murray, Philip I. ;

Denniston, Alastair K. .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (06) :700-708

[5] Systemic therapies for inflammatory eye disease: Past, Present and Future [J].

Denniston, Alastair K. ;

Dick, Andrew D. .

BMC OPHTHALMOLOGY, 2013, 13

[6] Uveitis: A potentially blinding disease [J].

Durrani, OM ;

Meads, CA ;

Murray, PI .

OPHTHALMOLOGICA, 2004, 218 (04) :223-236

[7] Food and Drug Administration Procedures for New Drug and Device Approvals [J].

Holland, Gary N. ;

Eydelman, Malvina B. ;

Cunningham, Brad ;

Chambers, Wiley A. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 161 :1-3

[8] Adalimumab in Patients with Active Noninfectious Uveitis [J].

Jaffe, Glenn J. ;

Dick, Andrew D. ;

Brezin, Antoine P. ;

Quan Dong Nguyen ;

Thorne, Jennifer E. ;

Kestelyn, Philippe ;

Barisani-Asenbauer, Talin ;

Franco, Pablo ;

Heiligenhaus, Arnd ;

Scales, David ;

Chu, David S. ;

Camez, Anne ;

Kwatra, Nisha V. ;

Song, Alexandra P. ;

Kron, Martina ;

Tari, Samir ;

Suhler, Eric B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (10) :932-943

[9] Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema [J].

Levin, Marc H. ;

Pistilli, Maxwell ;

Daniel, Ebenezer ;

Gangaputra, Sapna S. ;

Nussenblatt, Robert B. ;

Rosenbaum, James T. ;

Suhler, Eric B. ;

Thorne, Jennifer E. ;

Foster, C. Stephen ;

Jabs, Douglas A. ;

Levy-Clarke, Grace A. ;

Kempen, John H. .

OPHTHALMOLOGY, 2014, 121 (02) :588-+

[10]

National Institute for Health and Clinical Excellence, 2017, AD DEX TREAT NON UV

← 1 2 →